Invention Grant
- Patent Title: Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors
-
Application No.: US15321609Application Date: 2015-06-30
-
Publication No.: US10093629B2Publication Date: 2018-10-09
- Inventor: Satoshi Yamamoto , Junya Shirai , Tsuneo Oda , Mitsunori Kono , Atsuko Ochida , Takashi Imada , Hidekazu Tokuhara , Yoshihide Tomata , Naoki Ishii , Michiko Tawada , Yoshiyuki Fukase , Tomoya Yukawa , Shoji Fukumoto
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: JP2014-136359 20140701; JP2014-262775 20141225
- International Application: PCT/JP2015/069370 WO 20150630
- International Announcement: WO2016/002968 WO 20160107
- Main IPC: C07D217/26
- IPC: C07D217/26 ; C07D491/056 ; C07D491/048 ; C07F7/08 ; C07D471/04 ; A61K31/4375 ; A61K31/472 ; A61K31/4741 ; C07D217/14 ; C07D491/14
Abstract:
Provided are heterocyclic compounds having a RORγt inhibitory action represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
Public/Granted literature
- US20170144973A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS RETINOID-RELATED ORPHAN RECEPTOR (ROR) GAMMA-T INHIBITORS Public/Granted day:2017-05-25
Information query
